Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Yttrium-90 therapy and 99MTc pertechnetate knee uptake measurements in the management of rheumatoid arthritis.

Literature DB >> 6303231

Yttrium-90 therapy and 99MTc pertechnetate knee uptake measurements in the management of rheumatoid arthritis.

Abstract

Twenty-eight knees with chronic arthritis and effusion were treated with intra-articular 90Y. Synovial activity was assessed by measuring 99mTc pertechnetate uptake. There was a significant difference in uptake between controls and patients. Those who had a good response to 90Y (15 patients) showed a significant decrease in uptake, not seen in those who failed to respond. The pattern of 90Y distribution was examined and appeared to correspond to areas of increased synovial activity; these patterns and their significance have not been previously reported. Factors which could help to predict response to 90Y are discussed.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1983 PMID： 6303231 PMCID： PMC1001085 DOI： 10.1136/ard.42.2.132

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

19 in total

1. EVALUATION OF INTRA-ARTICULAR COLLOIDAL GOLD AU 198 IN THE TREATMENT OF PRESISTENT KNEE EFFUSIONS.

Authors: B M ANSELL; A CROOK; J R MALLARD; E G BYWATERS
Journal: Ann Rheum Dis Date: 1963-11 Impact factor: 19.103

Review 2. Radioactive colloids in the treatment of arthritis. Review of published and personal results. Criteria for selection of patients.

Authors: J M Gumpel
Journal: Ann Rheum Dis Date: 1973-12 Impact factor: 19.103

3. An investigation of radioactive yttrium (90Y) for the treatment of chronic knee effusions.

Authors: H L Prichard; J F Bridgman; N M Bleehen
Journal: Br J Radiol Date: 1970-07 Impact factor: 3.039

4. Use of yttrium 90 in persistent synovitis of the knee. I. Retention in the knee and spread in the body after injection.

Authors: J M Gumpel; E D Williams; H I Glass
Journal: Ann Rheum Dis Date: 1973-05 Impact factor: 19.103

5. Chromosome damage after intra-articular injections of radioactive yttrium. Effect of immobilization on the biological dose.

Authors: A de la Chapelle; A Rekonen; M Oka; A Ruotsi
Journal: Ann Rheum Dis Date: 1972-11 Impact factor: 19.103

6. Cytogenetic and scanning study of patients receiving intra-articular injections of gold-198 and yttrium-90.

Authors: A C Stevenson; J Bedford; G W Dolphin; R J Purrott; D C Lloyd; A G Hill; H F Hill; J M Gumpel; D Williams; J T Scott; N W Ramsey; F E Bruckner; C B Fearn
Journal: Ann Rheum Dis Date: 1973-03 Impact factor: 19.103

7. Measurement of systemic inflammatory activity in rheumatoid arthritis by the 99mTc method.

Authors: M Oka; A Rekonen; A Ruotsi; J Kuikka
Journal: Scand J Rheumatol Date: 1973 Impact factor: 3.641

8. Biological hazards of radiation.

Authors: G W Dolphin
Journal: Ann Rheum Dis Date: 1973-12 Impact factor: 19.103

9. The pertechnetate joint scan. II. Clinical correlations.

Authors: F A Green; M T Hays
Journal: Ann Rheum Dis Date: 1972-07 Impact factor: 19.103

10. 99m-technetium scintiphotography in arthritis. I. Technic and interpretation.

Authors: D J McCarty; R E Polcyn; P A Collins; A Gottschalk
Journal: Arthritis Rheum Date: 1970 Jan-Feb

13 in total

1. The intra-articular distribution of 90yttrium does not influence the clinical outcome of radiation synovectomy of the knee.

Authors: Z N Jahangier; F M van der Zant; J W G Jacobs; H G Riedstra; G M M Gommans; J F Verzijlbergen; J W J Bijlsma; J W van Isselt
Journal: Ann Rheum Dis Date: 2007-01-12 Impact factor: 19.103

2. Efficacy of radiosynovectomy of the knee in rheumatoid arthritis: evaluation with magnetic resonance imaging.

Authors: A Alonso-Ruiz; F Pérez-Ruiz; M Calabozo; F Saez; J Ignacio Pijoan; E Ruiz-Lucea; I Aretxabala; G Ríos
Journal: Clin Rheumatol Date: 1998 Impact factor: 2.980

3. Radiosynoviorthesis of the knee: a doubleblind trial of 1 versus 5 mCi Gold-198.

Authors: R M Van Soesbergen; C A Hoefnagel; H R Marcuse; P F Dijkstra; H J Bernelot Moens
Journal: Clin Rheumatol Date: 1988-06 Impact factor: 2.980

4. Treatment of chronic knee effusions with 90yttrium-correlation of in vitro radiation and chemical effects with clinical results at three and six months.

Authors: P Sheldon; C Webb; S Roy; F Nichol; J McKenzie; N Williams; G Zaphiropoulos
Journal: Rheumatol Int Date: 1986 Impact factor: 2.631

5. Intra-articular radioactive yttrium and triamcinolone hexacetonide: an inconclusive trial. Arthritis and Rheumatism Council Multicentre Radiosynoviorthesis Trial Group.

Authors:
Journal: Ann Rheum Dis Date: 1984-08 Impact factor: 19.103

Review 6. Exposure, metabolism, and toxicity of rare earths and related compounds.

Authors: S Hirano; K T Suzuki
Journal: Environ Health Perspect Date: 1996-03 Impact factor: 9.031

7. Treatment of pigmented villonodular synovitis of the knee with yttrium-90 silicate: prospective evaluations by arthroscopy, histology, and 99mTc pertechnetate uptake measurements.

Authors: M J Franssen; A M Boerbooms; R P Karthaus; W C Buijs; L B van de Putte
Journal: Ann Rheum Dis Date: 1989-12 Impact factor: 19.103

8. Synovectomy of the knee with 90Y.

Authors: P F Spooren; J J Rasker; R P Arens
Journal: Eur J Nucl Med Date: 1985

9. Beta-particle dosimetry in radiation synovectomy.

Authors: L S Johnson; J C Yanch; S Shortkroff; C L Barnes; A I Spitzer; C B Sledge
Journal: Eur J Nucl Med Date: 1995-09

10. Treatment of pigmented villonodular synovitis with yttrium-90: changes in immunologic features, Tc-99m uptake measurements, and MR imaging of one case.

Authors: D Y Chen; J L Lan; S J Chou
Journal: Clin Rheumatol Date: 1992-06 Impact factor: 2.980